Finance

Lists
TTRX:NASDAQ
Turn Therapeutics Inc
USD 10,28
+0,98%
(+0,100) 1D
23 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
USD 10,59
High
USD 10,79
Low
USD 10,09
Mkt. cap
313,88 m
Avg. vol.
137,79 k
Volume
87,05 k
52-wk high
USD 16,45
52-wk low
USD 2,57
EPS
-USD 0,29
Shares outstanding
30,53 m
No. of employees
2
Open
USD 10,59
High
USD 10,79
Low
USD 10,09
Mkt. cap
313,88 m
Avg. vol.
137,79 k
Volume
87,05 k
52-wk high
USD 16,45
52-wk low
USD 2,57
EPS
-USD 0,29
Shares outstanding
30,53 m
No. of employees
2
News stories
From web sources and news partners
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersWestlake Village, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteturntherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to TTRX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current USD 10,28
USD 24,00 (+133,46%)
Average
USD 16,67 (+62,16%)
Lowest
USD 10,00 (-2,72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Karen Sterling
WBB Securities
Hold
Upgraded
USD 10,00
-2,7%
10/23/2026
Dev Prasad
Lucid Capital
Buy
Initiated
USD 24,00
+133,5%
09/24/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
USD 10,00
-2,7%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
USD 16,00
+55,6%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
USD 8,00
-22,2%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
496,95 k
477,65 k
638,75 k
Cost of revenue
-
496,95 k
477,65 k
638,75 k
Research and development expenses
158,70 k
34,93 k
109,43 k
475,06 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75 m
2,16 m
1,14 m
1,15 m
Operating expense
1,91 m
2,19 m
1,25 m
1,63 m
Total operating expenses
1,91 m
2,69 m
1,72 m
2,27 m
Operating income
-1,91 m
-2,69 m
-1,72 m
-2,27 m
Other non operating income
4,26 k
2,96 m
703,14 k
-3,34 m
EBT including unusual items
-1,90 m
279,07 k
-970,97 k
-5,85 m
EBT excluding unusual items
-1,90 m
279,07 k
-970,97 k
-5,85 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,90 m
279,07 k
-970,97 k
-5,85 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-0,04
-
Interest and investment income
5,11 k
14,18 k
49,68 k
-
Interest expense
-
-
-
-241,36 k
Net interest expenses
5,11 k
14,18 k
49,68 k
-241,36 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,90 m
-2,68 m
-1,71 m
-2,25 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme